Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison

Abstract

The cost-effectiveness of the pharmacotherapies varied significantly across the six study countries, however, in each case, the results would be considered favourable as compared to other common preventive pharmacotherapies.